Immune Boost Capital
Venture Capital and Private Equity Principals
Bridging Science and Investments for Improved Outcomes
About us
Immune Boost Capital (IBC) is an evergreen fund that invests in innovative therapies and technologies, leveraging the resources and relationships of the Arthritis National Research Foundation (ANRF).
- Website
-
https://www.immuneboostcapital.org
External link for Immune Boost Capital
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 1 employee
- Type
- Nonprofit
- Founded
- 2023
Updates
-
Immune Boost Capital will be at #ACR25. Please visit us at the Arthritis National Research Foundation booth at 2210-NP. We are excited to share this innovative new approach to funding early stage opportunities to bring new therapies forward into development. Visit our website for more information: www.immuneboostcapital.org Please reach out if you would like to schedule a meeting to learn more. #autoimmune #innovationinautoimmunedisease #rheumatology
-
-
Today, the Arthritis National Research Foundation (ANRF) announced the launch of Immune Boost Capital (IBC), a wholly owned 501(c)(3) subsidiary designed to fill a critical funding gap between academic discovery and commercial development in autoimmune disease. IBC is a philanthropic evergreen venture fund that will provide proof-of-concept funding for early-stage biotech companies and academic spinouts. Unlike traditional venture funds, 100% of returns will be reinvested to fuel future opportunities. Importantly, this initiative does not replace ANRF’s long-standing mission of funding innovative early-career investigators—it complements it, ensuring more promising science has the chance to advance into therapies for patients. This initiative has the potential to accelerate the development of transformative treatments for autoimmune disease. 👉 Read the full press release here: https://lnkd.in/gkuc3WQi 🌐 Learn more at: www.immuneboostcapital.org #AutoimmuneDisease #VenturePhilanthropy #BiotechInnovation #ANRF #ImmuneBoostCapital #AutoimmuneInnovation